# FOXD2

## Overview
FOXD2 is a gene that encodes the forkhead box D2 protein, a member of the forkhead family of transcription factors. These proteins are characterized by a distinct forkhead or winged-helix DNA-binding domain, which allows them to regulate the expression of genes involved in various biological processes, including development, differentiation, and tumorigenesis (Kim2023Forkhead). The forkhead box D2 protein plays a crucial role in modulating chromatin structure and accessibility, thereby influencing gene expression patterns. It is particularly significant in the context of colorectal cancer, where it interacts with chromatin modifiers such as MLL4 to exert tumor-suppressive effects (Kim2023Forkhead). The gene's involvement in cancer-related pathways and its potential as a biomarker for colorectal cancer highlight its clinical significance (Chen2023FOXD).

## Clinical Significance
FOXD2 is implicated in colorectal cancer (CRC), where it is overexpressed in cancerous tissues compared to normal tissues. This overexpression is observed in both colon adenocarcinoma (COAD) and rectal adenocarcinoma (READ) groups, suggesting its potential as a diagnostic and prognostic biomarker for CRC. The FOXD2 gene is associated with pathways related to tumorigenesis and cell proliferation, indicating its role in cancer progression (Chen2023FOXD).

Mutations in FOXD2 have been detected in CRC samples, and its related differentially expressed genes (DEGs) are linked to cytokine receptor pathways, which may contribute to cancer development (Chen2023FOXD). The FOXD2 subfamily, including FOXD2, is involved in pathways related to focal adhesion and oxidative phosphorylation, which are crucial for cancer cell survival and metastasis (Chen2023FOXD).

The long non-coding RNA FOXD2-AS1, associated with FOXD2, acts as an oncogene in various cancers, including glioma, papillary thyroid carcinoma, and ovarian cancer. It promotes cell proliferation, migration, and invasion by interacting with microRNAs, such as miR-506-5p and miR-4492, and is linked to poor prognosis in several cancers (Zhao2020Long; Dong2021Genomic; Gao2021Long).

## Interactions
FOXD2 interacts with the methyltransferase MLL4 (also known as KMT2D) to facilitate chromatin modifications. This interaction is crucial for the deposition of H3K4 monomethylation on target regions, which is associated with chromatin accessibility and the regulation of apoptotic processes in colorectal cancer cells (Kim2023Forkhead). The study suggests that FOXD2 recruits MLL4 to specific gene regions, thereby influencing gene expression and inhibiting colon cancer development (Kim2023Forkhead).

FOXD2's binding sites are strongly correlated with regions of chromatin openness, as evidenced by their overlap with ATAC GAIN/LOSS regions. This indicates that FOXD2 plays a significant role in modulating chromatin structure, which is essential for its function as a transcription factor (Kim2023Forkhead). Although the study does not provide detailed information on direct physical interactions with other proteins or nucleic acids, it highlights FOXD2's role in reprogramming enhancer interactions and altering chromatin landscapes to exert its tumor-suppressive effects (Kim2023Forkhead).

Overall, FOXD2's interactions with chromatin and MLL4 are central to its function in regulating gene expression and suppressing colorectal cancer progression.


## References


[1. (Kim2023Forkhead) Hyo-Min Kim, Byunghee Kang, Sohyun Park, Hyorim Park, Chan Johng Kim, Hyeonji Lee, Mijoung Yoo, Mi-Na Kweon, Sin-Hyeog Im, Tae Il Kim, and Tae-Young Roh. Forkhead box protein d2 suppresses colorectal cancer by reprogramming enhancer interactions. Nucleic Acids Research, 51(12):6143–6155, May 2023. URL: http://dx.doi.org/10.1093/nar/gkad361, doi:10.1093/nar/gkad361. This article has 6 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkad361)

[2. (Zhao2020Long) Juan Zhao, Xue-Bin Zeng, Hong-Yan Zhang, Jie-Wei Xiang, and Yu-Song Liu. Long non-coding rna foxd2-as1 promotes cell proliferation, metastasis and emt in glioma by sponging mir-506-5p. Open Medicine, 15(1):921–931, January 2020. URL: http://dx.doi.org/10.1515/med-2020-0175, doi:10.1515/med-2020-0175. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1515/med-2020-0175)

[3. (Gao2021Long) Jianfen Gao, Faqin Liu, Xia Zhao, and Ping Zhang. Long non‑coding rna foxd2‑as1 promotes proliferation, migration and invasion of ovarian cancer cells via regulating the expression of mir‑4492. Experimental and Therapeutic Medicine, February 2021. URL: http://dx.doi.org/10.3892/etm.2021.9738, doi:10.3892/etm.2021.9738. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/etm.2021.9738)

[4. (Dong2021Genomic) Xubin Dong, Cong Jin, Danxiang Chen, Yizuo Chen, Zhi-qiang Ye, Xiaohua Zhang, Xiaoli Huang, Wei Zhang, and Dian-na Gu. Genomic instability-related lncrna signature predicts the prognosis and highlights linc01614 is a tumor microenvironment-related oncogenic lncrna of papillary thyroid carcinoma. Frontiers in Oncology, September 2021. URL: http://dx.doi.org/10.3389/fonc.2021.737867, doi:10.3389/fonc.2021.737867. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2021.737867)

5. (Chen2023FOXD) FOXD subfamily genes serve as biomarkers and therapy targets in colorectal cancer. This article has 0 citations.